CN102266501A - 一种结石通茶组合物及其制备方法 - Google Patents
一种结石通茶组合物及其制备方法 Download PDFInfo
- Publication number
- CN102266501A CN102266501A CN 201110207284 CN201110207284A CN102266501A CN 102266501 A CN102266501 A CN 102266501A CN 201110207284 CN201110207284 CN 201110207284 CN 201110207284 A CN201110207284 A CN 201110207284A CN 102266501 A CN102266501 A CN 102266501A
- Authority
- CN
- China
- Prior art keywords
- calculus
- tea
- logical
- group
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 241001122767 Theaceae Species 0.000 title claims description 62
- 235000013616 tea Nutrition 0.000 claims description 61
- 235000015091 medicinal tea Nutrition 0.000 claims description 55
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 239000000796 flavoring agent Substances 0.000 claims description 6
- 235000019634 flavors Nutrition 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 235000019640 taste Nutrition 0.000 claims description 4
- 238000004064 recycling Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 20
- 208000004880 Polyuria Diseases 0.000 abstract description 8
- 230000000740 bleeding effect Effects 0.000 abstract description 8
- 230000035619 diuresis Effects 0.000 abstract description 8
- 206010030113 Oedema Diseases 0.000 abstract description 7
- 208000002193 Pain Diseases 0.000 abstract description 7
- 230000036407 pain Effects 0.000 abstract description 7
- 230000003285 pharmacodynamic effect Effects 0.000 abstract description 6
- 238000012360 testing method Methods 0.000 abstract description 6
- 230000002485 urinary effect Effects 0.000 abstract description 6
- 201000003146 cystitis Diseases 0.000 abstract description 5
- 208000001387 Causalgia Diseases 0.000 abstract description 3
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 201000008383 nephritis Diseases 0.000 abstract description 3
- 230000001939 inductive effect Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 abstract 4
- 241000220436 Abrus Species 0.000 abstract 1
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- 241000522190 Desmodium Species 0.000 abstract 1
- 241001598107 Imperata Species 0.000 abstract 1
- 241000737263 Lygodium Species 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000025505 Pyrrosia Species 0.000 abstract 1
- 240000008042 Zea mays Species 0.000 abstract 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract 1
- 229940126678 chinese medicines Drugs 0.000 abstract 1
- 235000005822 corn Nutrition 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 239000004575 stone Substances 0.000 abstract 1
- 208000019206 urinary tract infection Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 55
- 229940079593 drug Drugs 0.000 description 37
- 238000002474 experimental method Methods 0.000 description 26
- 241000700159 Rattus Species 0.000 description 23
- 230000002496 gastric effect Effects 0.000 description 23
- 238000001802 infusion Methods 0.000 description 23
- 241000699670 Mus sp. Species 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 230000037396 body weight Effects 0.000 description 14
- 239000012153 distilled water Substances 0.000 description 12
- 238000005516 engineering process Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 208000032843 Hemorrhage Diseases 0.000 description 7
- 238000012449 Kunming mouse Methods 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 235000010418 carrageenan Nutrition 0.000 description 7
- 229920001525 carrageenan Polymers 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 210000002700 urine Anatomy 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 208000000114 Pain Threshold Diseases 0.000 description 6
- 230000037040 pain threshold Effects 0.000 description 6
- -1 Dichlorodiphenyl Acetate Chemical compound 0.000 description 5
- 240000001624 Espostoa lanata Species 0.000 description 5
- 235000009161 Espostoa lanata Nutrition 0.000 description 5
- 206010018691 Granuloma Diseases 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000036592 analgesia Effects 0.000 description 4
- 229940113118 carrageenan Drugs 0.000 description 4
- 239000000679 carrageenan Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- 206010037596 Pyelonephritis Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000012931 Urologic disease Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000002224 dissection Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 208000000143 urethritis Diseases 0.000 description 2
- 208000014001 urinary system disease Diseases 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000036649 Dysbacteriosis Diseases 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003194 forelimb Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110207284 CN102266501B (zh) | 2011-07-25 | 2011-07-25 | 一种结石通茶组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110207284 CN102266501B (zh) | 2011-07-25 | 2011-07-25 | 一种结石通茶组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102266501A true CN102266501A (zh) | 2011-12-07 |
CN102266501B CN102266501B (zh) | 2012-12-05 |
Family
ID=45049081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110207284 Active CN102266501B (zh) | 2011-07-25 | 2011-07-25 | 一种结石通茶组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102266501B (zh) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102441122A (zh) * | 2011-12-13 | 2012-05-09 | 戴天高 | 一种治疗肾结石的中药配方及煎制方法 |
CN103041199A (zh) * | 2012-12-20 | 2013-04-17 | 周瑾 | 一种治疗尿路结石的中药组合物 |
CN103705772A (zh) * | 2013-12-30 | 2014-04-09 | 广西梧州制药(集团)股份有限公司 | 一种抗炎保肝的中药组合物及其制备方法 |
CN103705773A (zh) * | 2013-12-30 | 2014-04-09 | 广西梧州制药(集团)股份有限公司 | 一种抗菌消炎中药组合物及其制备方法 |
CN103705775A (zh) * | 2013-12-30 | 2014-04-09 | 广西梧州制药(集团)股份有限公司 | 一种保肝镇痛中药组合物及其制备方法 |
CN103735900A (zh) * | 2013-12-30 | 2014-04-23 | 广西梧州制药(集团)股份有限公司 | 一种抑石镇痛的中药组合物及其制备方法 |
CN103735901A (zh) * | 2013-12-30 | 2014-04-23 | 广西梧州制药(集团)股份有限公司 | 一种利尿抗炎的中药组合物及其制备方法 |
CN103735902A (zh) * | 2013-12-30 | 2014-04-23 | 广西梧州制药(集团)股份有限公司 | 一种抗炎抑石的中药组合物及其制备方法 |
CN103735904A (zh) * | 2013-12-30 | 2014-04-23 | 广西梧州制药(集团)股份有限公司 | 一种镇痛抗菌中药组合物及其制备方法 |
CN103735903A (zh) * | 2013-12-30 | 2014-04-23 | 广西梧州制药(集团)股份有限公司 | 一种抗菌抑石中药组合物及其制备方法 |
CN103751584A (zh) * | 2013-12-30 | 2014-04-30 | 广西梧州制药(集团)股份有限公司 | 一种抗炎镇痛中药组合物及其制备方法 |
CN103751583A (zh) * | 2013-12-30 | 2014-04-30 | 广西梧州制药(集团)股份有限公司 | 一种利尿保肝的中药组合物及其制备方法 |
CN104172418A (zh) * | 2014-08-31 | 2014-12-03 | 王月水 | 一种治疗泌尿性结石的醋饮及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1362163A (zh) * | 2001-01-02 | 2002-08-07 | 杨孟君 | 一种纳米结石通制剂药物及其制备方法 |
CN1824178A (zh) * | 2005-12-20 | 2006-08-30 | 王衡新 | 治疗泌尿系统疾病的中药制剂及其制备和质量控制方法 |
-
2011
- 2011-07-25 CN CN 201110207284 patent/CN102266501B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1362163A (zh) * | 2001-01-02 | 2002-08-07 | 杨孟君 | 一种纳米结石通制剂药物及其制备方法 |
CN1824178A (zh) * | 2005-12-20 | 2006-08-30 | 王衡新 | 治疗泌尿系统疾病的中药制剂及其制备和质量控制方法 |
Non-Patent Citations (2)
Title |
---|
《中国疗养医学》 王俊婷 体外冲击波结合中药治疗上尿路结石 , 第12期 * |
《卫生部颁药品标准中药成方制剂第十册》 19951231 国家药典委员会 结石通茶 , * |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102441122A (zh) * | 2011-12-13 | 2012-05-09 | 戴天高 | 一种治疗肾结石的中药配方及煎制方法 |
CN103041199A (zh) * | 2012-12-20 | 2013-04-17 | 周瑾 | 一种治疗尿路结石的中药组合物 |
CN103735904A (zh) * | 2013-12-30 | 2014-04-23 | 广西梧州制药(集团)股份有限公司 | 一种镇痛抗菌中药组合物及其制备方法 |
CN103735903A (zh) * | 2013-12-30 | 2014-04-23 | 广西梧州制药(集团)股份有限公司 | 一种抗菌抑石中药组合物及其制备方法 |
CN103705775A (zh) * | 2013-12-30 | 2014-04-09 | 广西梧州制药(集团)股份有限公司 | 一种保肝镇痛中药组合物及其制备方法 |
CN103735900A (zh) * | 2013-12-30 | 2014-04-23 | 广西梧州制药(集团)股份有限公司 | 一种抑石镇痛的中药组合物及其制备方法 |
CN103735901A (zh) * | 2013-12-30 | 2014-04-23 | 广西梧州制药(集团)股份有限公司 | 一种利尿抗炎的中药组合物及其制备方法 |
CN103735902A (zh) * | 2013-12-30 | 2014-04-23 | 广西梧州制药(集团)股份有限公司 | 一种抗炎抑石的中药组合物及其制备方法 |
CN103705772A (zh) * | 2013-12-30 | 2014-04-09 | 广西梧州制药(集团)股份有限公司 | 一种抗炎保肝的中药组合物及其制备方法 |
CN103705773A (zh) * | 2013-12-30 | 2014-04-09 | 广西梧州制药(集团)股份有限公司 | 一种抗菌消炎中药组合物及其制备方法 |
CN103751584A (zh) * | 2013-12-30 | 2014-04-30 | 广西梧州制药(集团)股份有限公司 | 一种抗炎镇痛中药组合物及其制备方法 |
CN103751583A (zh) * | 2013-12-30 | 2014-04-30 | 广西梧州制药(集团)股份有限公司 | 一种利尿保肝的中药组合物及其制备方法 |
CN103705772B (zh) * | 2013-12-30 | 2016-04-27 | 广西梧州制药(集团)股份有限公司 | 一种抗炎保肝的中药组合物及其制备方法 |
CN103735903B (zh) * | 2013-12-30 | 2015-12-09 | 广西梧州制药(集团)股份有限公司 | 一种抗菌抑石中药组合物及其制备方法 |
CN103705775B (zh) * | 2013-12-30 | 2016-04-27 | 广西梧州制药(集团)股份有限公司 | 一种保肝镇痛中药组合物及其制备方法 |
CN104172418A (zh) * | 2014-08-31 | 2014-12-03 | 王月水 | 一种治疗泌尿性结石的醋饮及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102266501B (zh) | 2012-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102266501B (zh) | 一种结石通茶组合物及其制备方法 | |
JP2016503040A (ja) | 頭痛治療用医薬組成物、及びその調製法 | |
CN101461926B (zh) | 一种治疗乳腺增生的药物组合物及其制备方法 | |
CN101485870A (zh) | 一种健胃驱虫药 | |
CN102100758B (zh) | 一种用于止痛消肿的青鹏凝胶剂及其制备方法 | |
CN108126026A (zh) | 虫草芪参胶囊的制备方法 | |
CN103285060A (zh) | 一种用于活血止痛、去瘀生新的中药组合物及其制备方法 | |
CN101849950A (zh) | 救必应酸在制备调血脂的药物中的应用 | |
KR101719709B1 (ko) | 인동 및 지황의 혼합 추출물을 포함하는 대사성 질환 예방 또는 치료용 조성물 | |
CN101129971A (zh) | 治疗妇女痛经、月经不调的中药组合物及其制备方法 | |
CN101554406B (zh) | 桑树皮降糖药用活性物质提取工艺及其配方 | |
US9089577B1 (en) | Water extracts of cinnamon and Radix Astragali | |
CN103432420B (zh) | 一种治疗糖尿病的中药组合物及其制备方法和检测方法 | |
CN101450127A (zh) | 一种木瓜总酚酸提取物及其用途 | |
CN102363017B (zh) | 一种用于清热解毒、活血化瘀、利湿化痰的中药组合物及其制备方法 | |
CN103006832B (zh) | 一种升血小板中药组合物及其制备方法 | |
CN101406556B (zh) | 一种用于治疗急性前列腺炎、前列腺增生的中药制剂及其制备方法 | |
CN102233084B (zh) | 一种用于治疗前列腺炎的中药组合物及其制备方法 | |
CN103479814A (zh) | 一种治疗痛风的中药组合物 | |
CN108837045A (zh) | 一种用于小儿急性扁桃体炎、急性咽炎的中药组合物的制备方法 | |
CN108704036A (zh) | 一种治疗痛风的复方中药制剂及其制备方法 | |
CN101926955B (zh) | 一种治疗胃病的药物 | |
CN109381454B (zh) | 一种润肠通便胶囊及其制备方法 | |
CN102526289A (zh) | 一种麻仁润肠丸制剂及其制备方法 | |
CN102579601A (zh) | 一种治疗类风湿性关节炎的药物组合物及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20111207 Assignee: SHAANXI KANGHUI PHARMACEUTICAL Co.,Ltd. Assignor: Wang Jianghong Contract record no.: 2013990000030 Denomination of invention: Jieshitong tea composition and preparation method thereof Granted publication date: 20121205 License type: Common License Record date: 20130124 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231230 Address after: No. 12-2-101, Shangshan Jiayuan, Middle Section of Century Avenue, Qindu District, Xianyang City, Shaanxi Province, 712000 Patentee after: Xianyang Guangtai Pharmaceutical Technology Co.,Ltd. Address before: 712000 No.1, 1st floor, unit 5, Zhonghong Times Square, No.16 Renmin Middle Road, Qindu District, Xianyang City, Shaanxi Province Patentee before: Wang Jianghong |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240122 Address after: No. 36 Yanzhi Road, High tech Industrial Development Zone, Xianyang City, Shaanxi Province, 712000 Patentee after: Shaanxi Junkeli Pharmaceutical Technology Co.,Ltd. Country or region after: China Address before: No. 12-2-101, Shangshan Jiayuan, Middle Section of Century Avenue, Qindu District, Xianyang City, Shaanxi Province, 712000 Patentee before: Xianyang Guangtai Pharmaceutical Technology Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |